62856-350 : Lusedra 35 mg/ml Intravenous Injection

Labeler: Eisai, Inc
Product Type: Human Prescription Drug
Drug Name:  Lusedra
Dosage Form: Intravenous Injection
Application #: NDA022244
Rev. Date: 
CSA Schedule: CIV (US) [1]

[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 62856-350-08: 8 VIAL IN 1 TRAY (62856‑350‑08) > 30 ML IN 1 VIAL
  • 62856-350-58: 8 VIAL IN 1 TRAY (62856‑350‑58) > 30 ML IN 1 VIAL

Active Ingredients:

  • Fospropofol Disodium

Dosage Strength:

  • 35 mg/mL


Scan the QR code below to easily reference this data in the future:

NDC 62856-350 QR Code

< Prev: 62856-290Next: 62856-389 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA